| Alli EU/1/07/401/12-15 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Alli EU/1/07/401/1-6 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Alli EU/1/07/401/7-11 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Allopurinol 100 mg tablets PA2315/219/001 |
Allopurinol |
Accord Healthcare Ireland Ltd. |
Marketed |
| Allopurinol 300 mg tablets PA2315/219/002 |
Allopurinol |
Accord Healthcare Ireland Ltd. |
Marketed |
| Allopurinol Clonmel 100 mg tablets PA0126/412/001 |
Allopurinol |
Clonmel Healthcare Ltd |
Not marketed |
| Allopurinol Clonmel 200 mg tablets PA0126/412/002 |
Allopurinol |
Clonmel Healthcare Ltd |
Not marketed |
| Allopurinol Clonmel 300 mg tablets PA0126/412/003 |
Allopurinol |
Clonmel Healthcare Ltd |
Not marketed |
| Allopurinol Teva 100 mg tablets PA0749/099/001 |
Allopurinol |
Teva Pharma B.V. |
Marketed |
| Allopurinol Teva 300 mg tablets PA0749/099/003 |
Allopurinol |
Teva Pharma B.V. |
Marketed |
| Alluzience, 200 Speywood units/mL, solution for injection PA1613/004/001 |
Botulinum Toxin A - Haemagglutinin Complex |
Ipsen Pharma |
Marketed |
| Almogran 12.5 mg film-coated tablet PA0968/001/001 |
Almotriptan |
Almirall, S.A. |
Marketed |
| Alopur 100 mg tablets PA0711/154/001 |
Allopurinol |
Rowex Limited, |
Marketed |
| Alopur 300 mg tablets PA0711/154/002 |
Allopurinol |
Rowex Limited, |
Marketed |
| Aloxi 250 micrograms solution for injection EU/1/04/306/001 |
Palonosetron (as hydrochloride) |
Helsinn Birex Pharmaceuticals Limited |
— |
| Aloxi 500 micrograms soft capsules EU/1/04/306/002-003 |
Palonosetron (as hydrochloride) |
Helsinn Birex Pharmaceuticals Limited |
— |
| Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PA1824/007/001 |
Brimonidine tartrate |
AbbVie Limited |
Marketed |
| Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PPA0465/413/001 |
Brimonidine tartrate |
PCO Manufacturing Ltd. |
— |
| Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PPA1463/252/001 |
Brimonidine tartrate |
IMED Healthcare Ltd., |
— |
| Alprazolam 0.25 mg tablets PA0711/140/001 |
Alprazolam |
Rowex Limited, |
Marketed |
| Alprazolam 0.5 mg tablets PA0711/140/002 |
Alprazolam |
Rowex Limited, |
Marketed |
| Alprazolam Grindeks 1 mg tablets PA22992/028/003 |
Alprazolam |
AS Grindeks |
Not marketed |
| Alprazolam Grindeks 250 microgram tablets PA22992/028/001 |
Alprazolam |
AS Grindeks |
Not marketed |
| Alprazolam Grindeks 500 microgram tablets PA22992/028/002 |
Alprazolam |
AS Grindeks |
Not marketed |
| Alprazolam Krka 1 mg tablets PA1347/097/003 |
Alprazolam |
KRKA, d.d., Novo mesto |
Marketed |
| Alprazolam Krka 250 microgram tablets PA1347/097/001 |
Alprazolam |
KRKA, d.d., Novo mesto |
Marketed |
| Alprazolam Krka 500 microgram tablets PA1347/097/002 |
Alprazolam |
KRKA, d.d., Novo mesto |
Marketed |
| ALPROLIX 1000 IU powder and solvent for solution for injection EU/1/16/1098/003 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 2000 IU powder and solvent for solution for injection EU/1/16/1098/004 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 250 IU powder and solvent for solution for injection EU/1/16/1098/001 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 3000 IU powder and solvent for solution for injection EU/1/16/1098/005 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 500 IU powder and solvent for solution for injection EU/1/16/1098/002 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| Alsemora 10 mg film-coated tablets PA22992/038/001 |
Memantine hydrochloride |
AS Grindeks |
Not marketed |
| Alsemora 20 mg film-coated tablets PA22992/038/002 |
Memantine hydrochloride |
AS Grindeks |
Not marketed |
| Altavita D3 50,000 IU oral solution PA1876/002/001 |
Cholecalciferol |
Consilient Health Limited |
Not marketed |
| altavitaD3 1,000 IU soft capsules PA1876/005/001 |
Cholecalciferol |
Consilient Health Limited |
Marketed |
| altavitaD3 25,000 IU soft capsules PA1876/004/003 |
Cholecalciferol (02) |
Consilient Health Limited |
Marketed |
| AltavitaD3 25,000IU oral solution PA1876/002/002 |
Colecalciferol |
Consilient Health Limited |
Marketed |
| altavitaD3 50,000 IU soft capsules PA1876/004/004 |
Cholecalciferol (02) |
Consilient Health Limited |
Marketed |
| altavitaD3 7,000 IU soft capsules PA1876/005/002 |
Cholecalciferol |
Consilient Health Limited |
Marketed |
| ALTUVOCT 1 000 IU Powder and solvent for solution for injection EU/1/24/1824/004 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 2 000 IU Powder and solvent for solution for injection EU/1/24/1824/005 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 250 IU Powder and solvent for solution for injection EU/1/24/1824/001 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 3 000 IU Powder and solvent for solution for injection EU/1/24/1824/006 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 4 000 IU Powder and solvent for solution for injection EU/1/24/1824/007 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 500 IU Powder and solvent for solution for injection EU/1/24/1824/002 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 750 IU Powder and solvent for solution for injection EU/1/24/1824/003 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| Alunbrig 180 mg film-coated tablets EU/1/18/1264/009-010 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alunbrig 30 mg film-coated tablets EU/1/18/1264/001-004 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alunbrig 90 mg film-coated tablets EU/1/18/1264/005-008 |
Brigatinib |
Takeda Pharma A/S |
— |